MPs should beware of any universal pharmacare program, says the Canadian Pharmacists Association. The group’s lobbyist disputed drug cost warnings by a federal agency, the Patented Medicine Prices Review Board, and said universal coverage would cost billions: “We’re talking about pharmacare, not pharma cost”.
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
